Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07382596 · ClinicalTrials.gov registry record · Phase 4

Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD

A Phase 4 study, sponsored by Dr. Dean Reeves Clinic.

Recruiting
Registry status
Phase 4
Development phase
50
Enrollment target

NCT07382596: Recruiting Phase 4 study, sponsored by Dr. Dean Reeves Clinic.

NCT07382596 is a Phase 4 study that is actively recruiting participants, run by Dr. Dean Reeves Clinic. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07382596, a Phase 4 study, is actively recruiting participants, sponsored by Dr. Dean Reeves Clinic.

RECRUITING
Registry status
Phase 4
Development phase
50 participants
Enrollment target

Study Summary

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with an injection control of normal saline (NS)

Primary Outcome

Minimum 17 Maximum 85 Higher scores mean worse outcome

Interventions

  • DRUG Dextrose 5% in water bilateral injection
  • DRUG Normal saline bilateral injection

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-05-16
Est. Completion 2030-04-01
Phase Phase 4
Dr. Dean Reeves Clinic

4 total trials

What NCT07382596 shows while recruiting

NCT07382596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Dextrose 5% in water bilateral injection is the first listed.

NCT07382596 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07382596 about?

NCT07382596 is a clinical study titled "Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD". PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PT...

What is the current status of trial NCT07382596?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2026-05-16. Estimated completion is 2030-04-01.

What interventions are being tested in trial NCT07382596?

The interventions under investigation include: Dextrose 5% in water bilateral injection (DRUG), Normal saline bilateral injection (DRUG).

Who is sponsoring clinical trial NCT07382596?

This trial is sponsored by Dr. Dean Reeves Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07382596's enrollment target sits among peer trials

50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07382596, the US trial registry maintained by the National Library of Medicine. NCT07382596 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.